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Introduction:
Based largely on adult studies correlating hemodialysis (HD) mortality and morbidity with small solute clearance (urea K d t/V), the 1997 Dialysis Outcome Quality Initiative (DOQI) recommended monthly urea kinetic studies in children receiving maintenance HD, suggesting a minimum delivered K d t/V of 1.2 [2] . Extrapolation from adult studies may be problematic, as more appropriate pediatric outcome measures -such as growth, school performance, or pubertal development -might lead to very different conclusions as to the relative importance of the small molecular weight toxins for which urea is a surrogate marker. Prior to the introduction of recombinant human growth hormone (rhGH), mean annual loss in height standard-deviation score (∆HSDS) in prepubertal HD patients was -0.4 to -0.8 SD/year [3] . However, we have recently described normal growth rates, catch-up growth, and normal puberty with intensive nutritional support and hemodialysis clearance in prepubertal patients treated without rhGH [1] . With a weekly treatment time of ~ 15h and a single pool urea K d t/V of ~ 2.0, the mean annual ∆HSDS was > +0.3 SD/year, and predicted final adult height fell generally within 2 SD of genetic potential.
The standard variable volume, single pool (VVSP) urea kinetic model recommended for this purpose is also less satisfactory in children, predicting higher than observed blood urea nitrogen (BUN) concentrations during dialysis and failing to account for post-dialysis urea rebound, felt to reflect treatment-induced compartment effects [4, 5, 6, 7] . The net result is that dialysis appears spuriously more effective, with overestimation of dialyzer clearance K d , reduction in apparent urea distribution volume V, and attendant inflation of urea K d t/V. Although fully equilibrated (1h) post-treatment BUN samples will avoid these pitfalls, this was not felt to be practical on a routine basis [2] .
A multicompartmental model with intracellular (ICF) and extracellular (ECF) fluid spaces in series does predict intercompartmental disequilibration and urea rebound, but fixed compartment volumes are typically assumed to permit closed-form solutions (i.e. formulae predicting BUN as a function of time and other parameters) [8, 9] . If used to estimate unknown model parameters, this approach leads to more egregious errors than the single pool model, particularly in smaller patients with significant interdialytic weight gain. Although the differential equations are readily formulated for more realistic models, and even integrated numerically for investigational purposes, closed-form solutions are usually not possible, hindering routine application in a clinical setting. In the physical sciences, perturbation methods are often used to formulate approximate closed-form solutions to otherwise intractable differential equations [10] . These solutions rely on identification of 'small' parameters in the governing equations and are typically expressed as the solution to the simpler, solvable system in which these quantities are neglected (the unperturbed model) plus a correction term (perturbation).
Here, we reformulate a two compartment, variable volume model (VVDP). A straightforward perturbation expansion yields the VVSP model as unperturbed solution plus a correction term incorporating the effects of finite intercompartmental urea permeability. This solution fits well with the experimental data and furnishes reliable estimates of equilibrated kinetic parameters in typical pediatric HD studies. We then retrospectively reanalyse 292 monthly urea kinetic studies collected on the prepubertal patients from our earlier report of growth, felt to be unequivocally well-dialyzed on the basis of growth rates and pubertal development. These data furnish an estimate for the dialysis dose needed to sustain normal growth and development.
Patients and methods:
The 12 patients described in our earlier report, all the prepubertal patients receiving long-term maintenance HD in our center from 1991 until the introduction of rhGH in 1997, are fully characterised in [1] , including details of diagnosis, treatment, nutritional supplements, metabolic control, routine urea kinetic studies, and growth. Validation of the VVDP model involved 15 patients presented in Table 1 :
From our unit, 11 equilibrated urea kinetic studies were performed (mean treatment duration 283 ± 27 min), with patients 1 and 2 furnishing duplicate studies separated from the initial assessment by 3 and 6 months, respectively. Published data were reanalysed for six historical cases, included because of a relatively short treatment duration (142 ± 30 min) [5, 6] . Dialyzer urea clearance K d (whole blood, ml/min) was measured by the AV gradient method (appendix, eq. 1). The blood pump was calibrated prior to each study, and a commercial indicator-dilution technique was used to measure blood flow and exclude access recirculation (Transonic TM ) [11] , the latter corroborated in each case by the multiple-BUN method (eq. 2). BUN sampling (mM, whole blood) was typically hourly from the inlet side of the dialyzer during treatment ('slow-flow ' technique [2] ) and included pre-dialysis(C 0 ), enddialysis (C 1 ), equilibrated one hour post-dialysis (C 1eq ), and a second pre-dialysis sample (C 2 ) before the next treatment. The end-dialysis specimen was drawn 5 minutes after dialysate flow stopped.
Residual renal urea clearance K r (ml/min) was calculated from interdialytic urine collections, and ultrafiltration rates (Q f , ml/min) were based on pre and post-treatment weights. For the historical cases (10) (11) (12) (13) (14) (15) , published data including C 0 , C 1 , C 1eq , and mid-treatment (C s ) BUNs, dialysis duration (T d , min), K d , Q f , K r , weight; and recirculation status [5, 6] .
The VVDP perturbation solution is detailed in the appendix, where equation (9) predicts urea concentration as a function of time and the other model parameters. For the VVSP, FVDP, and VVDP models, estimates of V and G (K d specified by the user) or K d and G (V specified) are obtained by iterative methods, minimising the discrepancy between observed and predicted BUN as described in the appendix. Calculation of K d t/V used blood water K d , and protein catabolic rate (PCR) was calculated by the Borah equation (PCR = 0.262 * G + 0.294 * V, for G in µmol/min, V in liters, and PCR in g/day) and normalised to V/ 0.58 (nPCR) [12] . The errors associated with the various models are expressed relative to the reference values from the single pool analysis with measured K d and equilibrated post-dialysis BUN (C 1eq ). For both two pool models, intercompartmental urea mass transfer K ei was assumed to be ~10 ml/min/kg [5, 6, 13] . and the ratio of extracellular to intracellular volume (V e /V i ) at dry weight was assumed to be ~1/3 [14] . The Smye method predicts C 1eq based on intradialytic samples (C 0 , C s , C 1 ); the predicted value is then used with the VVSP to estimate equilibrated parameters [6, 15] . The Daugirdas rate equation furnishes a semi-empiric estimate of equilibrated K d t/V based on the standard single pool result and dialysis duration T d [16] .
For patients 2, 4, 7, 8, and 9, deemed to be in a clinical steady-state (no intercurrent illnesses and no dietary or dialysis prescription changes in the previous week), results of 2 BUN (steady-state) and 3 BUN sampling were formally compared as described in the appendix. Pre-and end-treatment BUNs were collected for a 2 week period (7 consecutive treatments for all but patient 9, in whom only 4 consecutive studies were obtained due to a schedule change). In addition, K d , blood flow, and recirculation were measured at outset and used to establish urea volume V. Blood flow was verified with each treatment. For the retrospective analysis in Table 5 , anthropometric estimates of total body water based on gender and height were supplied to estimate K d [17] .
DOQI advises that residual renal clearance be expressed as the equivalent dialyzer clearance needed to replace K r and maintain the same pre-dialysis BUN [2] . In practice, it may be approximated by (K t/V) renal = k K r /V, with k = 5.5 for thrice weekly dialysis and 6.5 for twice weekly dialysis (K r in ml/min, V in liters) [18, 19] . To evaluate k in children modelled with the VVDP, we simulated symmetric dialysis schedules (3, 4, or 5 weekly treatments, for a total of 15h/week) in 4 typical pediatric scenarios (weights 15, 30, 45, 60 kg; Q f = 90 ml/kg/week; C 0 = 25 mM; and G = 3 µmol/kg/min). K d was then systematically varied from 2 -5.5 ml/min/kg, and K r was varied from 0-6 ml/min/1.73 m is also freely available from the author (AS). Statistical analysis was performed using SAS 6.12 (SAS Institute, Durham, NC). Mean errors relative to reference values were compared by one way ANOVA, with significant group differences (p < 0.05) localised by post-hoc application of the pairwise Least Significant Difference test. Confidence intervals on the discrepancy between different estimates of the same parameter are calculated as Bland-Altman 95% limits of agreement [20] . also predicts higher than observed intradialytic BUN, particularly late in dialysis. As shown here, the VVDP model predicts both intercompartmental urea disequilibration and the post-treatment rebound phase, with a better fit to the observed data likely to yield improved parameter estimates. Table 2 compares reference values from the equilibrated single pool model with estimates derived from the VVSP, FVDP, VVDP, Smye method and rate equation using standard pre-and endtreatment BUN. Both the unequilibrated VVSP and FVDP models significantly underestimated urea distribution volume V compared to the VVDP (-2.2 ± 3.6% body weight). The group difference was significant (ANOVA p < 0.001) and localised to the comparison of VVDP with VVSP (p=0.002) and FVDP (p<0.001). As a consequence, both the unequilibrated VVSP and FVDP models overestimated Without a second pre-dialysis BUN for the historical cases, estimation of urea generation (G) and protein catabolic (PCR) rates involved only the 11 studies performed in our unit. In both cases, the VVSP estimates were associated with a larger errors than the VVDP. For G, mean errors were, respectively, -8.4 ± 3.6 vs -2.6 ± 5.8 µmol/min (paired t, p=0.01). For PCR, errors were -2.9 ± 1.0 vs -0.8 ± 1.6 g/d (p=0.005). In the calculation of nPCR, underestimation of V by the VVSP will partially offset this error, with a mean discrepancy of 0.06 ± 0.05 g/kg/d compared to 0.02 ± 0.05 g/kg/d for the
Results:
Reproducibility of parameter estimates was assessed by sequential studies in 5 patients deemed to be in a clinical steady-state, with no intercurrent illness and no diet or dialysis schedule change in the previous week. Table 3 In practice, (Kt/V) renal ~ k . K r /V, where k is determined by formal kinetic modelling based on the notion of equivalent dialyzer clearance needed to replace K r and achieve the same pre-dialysis urea concentrations [2, 18, 19] . Table 4 We retrospectively reanalysed 292 monthly studies collected on the 12 prepubertal patients described in our earlier report [1] . Our treatment regimen consisted of 14.8±1.8h per week of hemodialysis, thrice weekly except as noted in Table 5 , and recommended nutritional intake (RNI) for energy and protein.
The latter was achieved with supplements, gavage feeds, and intradialytic parenteral nutrition.
Compared to RNI promoted by the American Dietetics Association for children on hemodialysis [21] , mean intake was 91% for calories and 156% for protein. The urea reduction ratio (URR) was 84.7 ± 4.9%. Despite earlier reports associating obesity with attempts to supplement calories beyond 70-80%
RNI [22] , no overt obesity was observed by conventional criteria. ), normalised protein catabolic rate (g/kg/day), and modelled dialyzer clearance K d (whole blood, ml/min/kg). All three kinetic parameters are significantly smaller in the two pool analysis (paired t, p < 0.001). Estimated (Kt/V) renal using the equivalence relationships defined in Table 4 is also shown.
Total Kt/V (dialyzer + residual renal, treatment 
Discussion:
Urea is regarded as a surrogate marker for small, dialyzable toxins derived from protein metabolism.
In isolation, blood concentrations are poor outcome predictors [23] . However, for a given protein catabolic rate ( ≈ steady-state protein intake), the National Co-operative Dialysis Study (NCDS)
identified time averaged urea concentration (TAC) as the most powerful predictor of treatment failure (death or hospitalisation) [24, 25] . Time on dialysis -a surrogate for clearance of 'middle molecules' whose elimination is less responsive to increased flow rates -was a significant but less powerful discriminator (hospitalisation) [26] . A 'mechanistic' re-analysis of the NCDS data introduced urea K d t/V, the number of times the total body water was cleared of urea per treatment and a measure of delivered dialysis dose when derived from kinetic modelling [27] . Prospective trials have subsequently confirmed the relationship between K d t/V and uremic symptoms, particularly anorexia [28] , and urea kinetics are widely used to identify discrepancies between delivered and prescribed HD dose [29, 30] .
More recently, it has been suggested that K d t/V in the range not examined by the NCDS might further reduce mortality [31] , prompting an controlled randomised trial with single pool K d t/V 1.2 vs 1.6 [32] .
Comparable data in children is lacking. Concern about applicability of the NCDS definition of adequacy to children is one issue. The pediatric literature has emphasised age-appropriate outcome measures, particularly growth and development [3, 22, 33] . There has also been long-standing concern with overestimation of dialysis dose in children by the standard VVSP model, which cannot account for the compartmental effects illustrated in Fig. 2 [4, 5, 6, 7] . More complex models have proven useful for investigational purposes, but lack of closed-form solutions and the number of parameters requiring a priori estimates make them less practical in a clinical setting [34] . There have been several ingenious approaches to closed-form solutions that reflect the multicompartmental nature of urea distribution and are more suitable for iterative curve fitting. The FVDP model also spuriously inflates apparent dialyzer clearance. Smye adapted it with his prediction formula for the equilibrated post-treatment BUN based on intradialytic samples [6] . It requires an additional BUN midtreatment, precluding analysis of previously collected studies, and the resulting estimate has a wide confidence interval, confirming a recent pediatric comparison [35] .
Unlike this series arrangement of ICF and ECF compartments, an alternate model with 2 parallel pools has also been proposed, in which urea sequestration occurs in poorly perfused organs, such as bone, skin and muscle [16, 36] . The two approaches are mathematically equivalent, with K ei replaced by Q L , the fraction of cardiac output to the low perfusion compartment [37] . The model predicts that prolonged, the absolute error in our patients with almost 5h of dialysis is comparable to that observed in the cases dialyzing for half as long and is likely to be clinically significant in some (range 0.14-0.32).
The proposed VVDP model is highly idealised, and the solution in eq. (9) is an approximate one. Still, it accurately predicts observed blood urea concentrations and reproduces the key treatment-induced compartmental effects. This good fit with observed data permits reliable estimates of equilibrated kinetic parameters using standard pre-and end-dialysis BUNs. Although it neglects osmotic flux, sodium ramping between 140-150 mM in our unit did not appear to influence the goodness of fit. It is also parsimonious in terms of additional parameters requiring a priori estimates, with only 2 beyond those of the VVSP: i) whole body urea mass transfer coefficient K ei, and ii) the ratio of ECF to ICF volume at dry weight. In adults, the former is ~ 800 ml/min/1.73 m 2 (reviewed in [13] ) Similar values have been reported from careful analysis of urea rebound in 6 pediatric patients [5, 6] . For the latter,
we adopt a value of 1/ 3 [14] .
The intrasubject variation in kinetic parameters in Table 3 is similar to the results of single pool modelling in children [38] . In adults, abbreviated 2 BUN (steady-state) sampling may be preferable to the 3 BUN method, since it is more easily performed, less dependent on a single interdialytic interval, and less prone to patient manipulation of a study in progress [39] . As shown here, the two methods produce virtually identical estimates for V, K d and K d t/V. This is not unexpected, since V and K d are principally determined by the intradialytic urea samples, while G and nPCR largely reflect the interdialytic kinetics. By reflecting protein balance for the whole week, the steady-state method is theoretically less prone to dietary indiscretions in the single interdialytic interval spanned by the 3 BUN samples. The smaller coefficient of variation for the steady-state estimates of G and nPCR suggest that this is equally true in children.
Because of study-to-study variability, it is important to consider only mean values for G and nPCR from repeat studies when making prescription changes. With this proviso, agreement between the two methods was again satisfactory, although the 3 BUN method is the only option when the steady-state assumption does not hold.
The notion of equivalence used to define the contribution of residual renal clearance (Kt/V) renal in terms of dialyzer clearance required to replace it and achieve the same blood urea concentrations is widely recognised. It is based on the NCDS conclusion that, for a given protein catabolic rate, blood urea concentration is the most important predictor of outcome [2, 18, 19, 25] . Although there is little comparable pediatric data, measuring renal clearance consistently is a prerequisite for carrying out Given the paucity of pediatric data relating outcome to delivered dialysis dose, reanalysis of our prepubertal cohort was thought warranted, to furnish a better estimate of the dialysis dose needed to sustain normal growth. Even if the NCDS experience can be extrapolated directly to uniquely pediatric manifestations of uremia, their recommendations were based on a protein intake of ≤1.1 g/kg/d, which
represented an inflection point on the therapy target modelling line. Above this, the target line begins to cross Kt/V isopleths in an upward direction [27] , an important consideration given current guidelines from the American Dietetics Association for children on hemodialysis (ranging from 3.3 g/kg/day for infants to 1.3-1.5 g/kg/day in teenagers) [1, 21] . Even though anabolism in growing children will contribute to a discrepancy between dietary protein intake and protein catabolic rate, this is small (0 .05 g/kg/d) even during periods of rapid growth [40, 41] . As these kinetic studies confirm, protein catabolism exceeded the NCDS standard (nPCR 1.52 ± 0.38, range 0.9 -2.2 g/kg/day), and increased dialysis requirements might therefore be expected.
The K d t/V estimate provided by the VVDP model moves our dose targets closer to the norm, but the combined Kt/V (1.95 ± 0.34, range 1.3-2.5) continues to exceed current guidelines. Although we attempt to maximise blood flow and dialyzer surface area, actual dialyzer clearance (4.4 ± 0.8 ml/min/kg) is considered conventional [41, 42] , not unexpected given practical limitations in pediatric access flows and maximally tolerated extracorporeal volumes. There is in fact little experience with high flow ('high flux') hemodialysis in children [43] , leaving time on dialysis as the principle means of augmenting clearance. We are reluctant to extrapolate our results to shorter treatment times, where small solute K d t/V is maintained by higher flows. This approach may compromise membrane-limited middle molecule clearance, which is minimally responsive to changes in flow rates. For a given TAC/PCR, time on dialysis (a surrogate measure of middle molecule clearance) was a significant predictor of morbidity in the NCDS, albeit less powerful than TAC [26, 44] . The relatively short followup (6 mo) also precluded appreciation of longer-term middle molecule toxicity. Moreover, the role of middle molecules in the pathogenesis of growth failure in children is not known.
We believe the experience at our center supports an upward revision in dose guidelines for children.
However, a multicenter, controlled trial should address this question prospectively and more clearly define treatment targets for various ages and subsets . We hope our results and the kinetic model developed and validated here will provide a starting point for such discussions.
Appendix:
A convenient closed-form solution is not available for the variable volume, two pool (VVDP) model illustrated in Figure 3 (see caption for definition of variables). Although digital computers and numeric integration permit investigation of more realistic models [34, 45] … etc, as in equation (7) below [10] .
Assumptions:
The following explicit assumptions underlie this derivation. c) The effect of access recirculation on dialyzer clearance is formally treated here, but cardiopulmonary recirculation is not, although it is amenable to similar analysis for patients with AV fistulae [47] . q f that appears in the scaled equations (5) may therefore be considered a second-order effect and neglected as long as f is small. During dialysis, both whole body and segmental bioimpedance data puts the slope of the extracellular vs total ultrafiltrate relationship close to unity (i.e. f ~ 0) [48, 49] . Similar data have been used to justify this assumption -essentially, constant ICF volume -in other multicompartment models, at least as a first order approximation [45, 50] . We assume this also applies for the interdialytic interval.
e) We will identify ε = ( K d +K r )/K ei as the 'small' parameter for the perturbation expansion. Off dialysis, this is certainly true. On dialysis, we requires blood water K d << K ei . In adults, K ei ~ 800 ml/min/1.73 m 2 (reviewed in [13] ). Pediatric data is more limited, although Smye et al assumed that K d / K ei < 0.4 in the derivation of their fixed volume model. Based on their analysis of rebound kinetics in 6 pediatric patients, we have assumed K ei ~ 10 ml/kg/min for clinical applications [5, 6] , with typical whole blood clearances of 3-4 ml/kg/min [41, 42] and blood water K d ~ 90% of these values.
Derivation: Dialyzer clearance includes both diffusive and convective urea flux, given by
In the event of access recirculation, effective clearance is obtained by replacing Q bi and C bi with Q p and C p , respectively. Blood flow continuity (Q bi = Q p + Q r ) and urea mass conservation (C bi Q bi = C p Q p + C bo Q r ) may be invoked to calculate the recirculation fraction: Q r /Q b = F r = (C p -C bi )/(C p -C bo ) (2) . If this fraction is known, it follows from (1) and (2) that the measured clearance K d may be used to estimate effective clearance K de [50, 51] :
If modelled (effective) K d differs significantly from expected K d , (3) may also be rearranged to calculate the recirculation fraction on the basis of this discrepancy. Mass balance considerations then lead to the following governing equations, where square brackets denote function arguments (e.g. y =
h[x] ), ∂ t indicates the time derivative, and K d refers to effective dialyzer clearance:
To identify parameters that are small independent of the choice of units, (4) must first be made nondimensional by appropriate scaling factors [52] . Q f ) (in non-dimensional units, g/ (V 0 C 0 (1-q f )) will verify that it is a particular solution. Without loss of generality, we therefore apply the WKB approximation to the homogenous case.
We identify ε = 1/k ei = (K d + K r ) / K ei as a 'small' parameter for the perturbation expansion (see assumption (e)). Essentially, the WKB method imposes on (6) a solution of the following form, where δ = ε j and S[τ] is a function of both τ and δ expanded as a power series in δ:
To determine the form of δ, we substitute (7) in (6) and first consider only those terms that are retained in the limit δ→ 0. By dominant balance [46] , (6) is seen to hold only if δ = ε. With this result, the substitution is repeated, this time retaining all terms, and coefficients of successive powers of ε are collected. When individually equated to zero, these yield a series of ordinary differential equations to be solved sequentially for S i [τ] . We consider here only the first-order approximation; since our goal is parameter estimation from observed blood urea concentrations, the utility of this approximation will be measured by goodness of fit to experimental data. substituted in (8b). These provide two independent solutions to (6) of the form specified by (7) . By virtue of linearity, the general solution is a superposition of these individual terms, restored to the original units and added to the particular solution of the inhomogenous equation to yield the following result: 
Iterative parameter estimates:
These results are used to determine unknowns K d , V, or G by minimising the error between predicted and observed ECF urea concentrations, here with Brent's conjugate gradient method in one dimension [53] . Using either (9) or the standard VVSP or FVDP prediction formulae (for the latter, eq 5.3-4 in [9] ), the same algorithm is used to fit V to C 0 and C 1 (intradialytic) with K d measured and G ~ 3 µmol/kg/min. Alternatively, K d may be estimated if V is specified from previous kinetic studies or anthropometric formulae. This value is then used with C 1 and C 2 (interdialytic) to calculate G, in turn used to refine the estimate of V (or K d ), and the process iterated until convergence ( ±1%). In a steady-state, C 2 may be omitted, and G fit instead to the assumption that pre-dialysis BUN equals C 0 at the same point in the previous (or next) weekly cycle, producing estimates of G and protein catabolic rate that reflect protein balance during the entire week instead of the single interdialytic interval spanned by C 1 and C 2 . For the two pool analyses, the only additional parameters requiring a priori estimates are K ei and the ratio of V e /V i at post-dialysis 'dry'
weight. Sensitivity analysis (not shown) demonstrates that the resulting predictions are relatively insensitive to imprecision in these estimates. Table 5 : (K d t/V) dp nPCR dp (K d ) dp (Kt/V) renal 
Tables:
Patients
Figure 3:Variable volume, two compartment urea kinetic model
Abbreviations: Vi = intracellular fluid (ICF) volume, Ci = ICF urea concentration, Ve = extracellular fluid (ECF) volume, Ce = ECF urea concentration, Kei = intercompartmental urea mass transfer coefficient, f = fraction of ultrafiltrate from ICF, Kr = residual renal urea clearance, G = urea generation rate, Qf = ultrafiltration rate (> 0) or interdialytic weight gain (< 0), Kd = dialyzer urea clearance. In the dialyzer-access circuit, flows (Q) and concentrations (C) refer to peripheral blood (p), dialyzer inlet (bi), dialyzer outlet (bo), and access recirculation (r). Concentrations, flows, and Kd here refer to blood water (whole blood C / 0.93, 0.9 . whole blood Q or Kd). 
